Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · Real-Time Price · USD
1.500
-0.070 (-4.46%)
At close: Feb 23, 2026, 4:00 PM EST
1.500
0.00 (0.00%)
After-hours: Feb 23, 2026, 6:02 PM EST
Chemomab Therapeutics Market Cap
Chemomab Therapeutics has a market cap or net worth of $9.23 million as of February 23, 2026. Its market cap has decreased by -76.46% in one year.
Market Cap
9.23M
Enterprise Value
-823.33K
1-Year Change
-76.46%
Ranking
Category
Stock Price
$1.50
Market Cap Chart
Since March 17, 2021, Chemomab Therapeutics's market cap has decreased from $631.18M to $9.23M, a decrease of -98.54%. That is a compound annual growth rate of -57.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 9.66M | -4.85% |
| Dec 31, 2025 | 10.16M | -70.24% |
| Dec 31, 2024 | 34.13M | 466.14% |
| Dec 29, 2023 | 6.03M | -83.65% |
| Dec 30, 2022 | 36.88M | -53.12% |
| Dec 31, 2021 | 78.67M | -87.54% |
| Mar 17, 2021 | 631.18M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| KALA BIO | 10.73M |
| Akari Therapeutics, | 10.71M |
| OSR Holdings | 10.65M |
| Pulmatrix | 9.86M |
| Bolt Biotherapeutics | 9.69M |
| BioVie | 9.50M |
| TransCode Therapeutics | 8.89M |
| CollPlant Biotechnologies | 8.87M |